About Us

Chemokine YS converges its focus on the application of current knowledge of the migration of vital body defense cells via specific molecular signals in immune mobilization onto 3 broad strategies of developing innovative capabilities in predictive, preventive and prescriptive medicines. In predictive chemokine medicine, we discover new biomarkers in the form of DNA and proteins as well as epigenetic molecules. In preventive chemokine medicine, we formulate proprietary functional foods and purpose driven supplements to enable human benefits in preventing major chronic ailments such as cancers and inflammation derived diseases. In prescriptive chemokine medicine, we innovate next generation of medicines to combat, treat and even cure oncological and inflammatory diseases via specifically targeting and neutralizing identified disease-causing novel chemokines and thereby effectively reducing the mechanistic burdens of such molecular root causes of the diseases.